Data Integrity and Annex 11 Compliance Support UK

GMP decisions are only as reliable as the data that supports them. W2 Cleanroom Consulting provides independent data integrity and EU GMP Annex 11 compliance support for pharmaceutical manufacturers, NHS aseptic services and regulated organisations across the UK.

We help clients assess data flows, governance, records and computerised-system controls against the risk to product quality, patient safety and reliable decision-making.

Support can address a specific system or finding, or form part of a wider data-integrity improvement and remediation programme.

What Data Integrity and Annex 11 Support Covers

• Data integrity gap assessment and governance

• ALCOA+ application across paper, hybrid and electronic records

• Annex 11 computerised-system control review

• User access, roles and segregation of duties

• Audit-trail configuration, review and escalation

• Electronic signatures and record retention

• Backup, restore, business continuity and archiving

• Interfaces, calculations, spreadsheets and manual transcription

• Data lifecycle and critical-data mapping

• Finding investigation, CAPA and remediation planning

Applying ALCOA+ in Practice

ALCOA+ is not a slogan or a one-off checklist. Records should be attributable, legible, contemporaneous, original and accurate, as well as complete, consistent, enduring and available. The controls needed depend on the data, process, technology and risk.

We trace how important data is generated, reviewed, changed, transferred, reported and retained. This reveals points where information could be lost, overwritten, recreated outside the approved system or reviewed without sufficient context.

See our guides to data integrity in GMP and ALCOA+.

Annex 11 Computerised-System Governance

Annex 11 expects computerised systems used in GMP activities to be appropriately controlled throughout their lifecycle. We review whether governance is proportionate to system risk and whether responsibilities are clear across system owners, process owners, users, Quality, IT and suppliers.

The assessment can cover validation status, access management, security, audit trails, incident and change management, periodic review, data transfer, backup, restore testing, business continuity and supplier oversight.

A Risk-Based Assessment Approach

1. Define critical data. Identify the information used to make GMP, product and patient-safety decisions.

2. Map the lifecycle. Trace creation, processing, review, reporting, retention and destruction.

3. Test controls. Review procedures, configuration, records and actual user practice.

4. Assess impact. Rank gaps according to data criticality, detectability and potential consequence.

5. Plan remediation. Set immediate controls, sustainable actions, owners and evidence.

6. Verify effectiveness. Confirm that technical and procedural controls remain effective in operation.

Common Data Integrity Weaknesses

• Shared or excessive user access

• Audit trails enabled but not meaningfully reviewed

• Uncontrolled spreadsheets or calculations

• Manual transcription without verification

• Incomplete metadata or missing original records

• Weak governance of system interfaces and exports

• Inadequate backup or restore evidence

• Periodic reviews that do not evaluate actual performance

• Supplier controls that do not cover data responsibilities

• CAPA that addresses symptoms but not the control environment

Data Integrity Remediation

Where a significant gap or inspection finding exists, we can support investigation, immediate risk control, retrospective assessment, CAPA design and governance of the remediation plan.

Our article on data integrity remediation explains how this differs from a narrow technical fix. Where validated state is affected, support can also connect to our validation lifecycle consultancy.

Regulatory Alignment

Our work considers EU GMP Chapter 4 Documentation, Annex 11 Computerised Systems, Annex 15 qualification and validation, and relevant expectations in Annex 1 for sterile manufacture. Quality risk management principles are applied according to the system and use.

The client retains responsibility for system approval, Quality decisions, data governance and regulatory commitments.

Typical Deliverables

• Data-integrity and Annex 11 gap-assessment report

• Critical-data and lifecycle map

• Risk-ranked remediation plan

• Audit-trail review framework

• Access and responsibility recommendations

• Periodic-review content framework

• Independent remediation or readiness review

Discuss Data Integrity Support

If you need an independent Annex 11 review, data-integrity gap assessment or support responding to a finding, contact W2 for a confidential discussion.

Email the W2 GMP consultancy team or explore the GxP Knowledge Centre.

Prepared and reviewed by: W2 Cleanroom Consulting GMP team. Last reviewed: 24 July 2026.

Independent Data Integrity and Annex 11 Consultancy